Trial intelligence / Profile preview

Tiotropium + Procaterol in Moderate COPD

NCT00394485Phase 4Terminated

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of procaterol in chronic obstructive pulmonary disease (COPD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started May 2006; status: terminated.

02

Drugs

procaterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00394485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00394485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call